loading
전일 마감가:
$1.02
열려 있는:
$1.01
하루 거래량:
52,366
Relative Volume:
0.36
시가총액:
$6.47M
수익:
-
순이익/손실:
$-6.07M
주가수익비율:
-0.1346
EPS:
-7.54
순현금흐름:
$-7.34M
1주 성능:
-11.40%
1개월 성능:
-5.61%
6개월 성능:
-27.86%
1년 성능:
-53.67%
1일 변동 폭
Value
$0.9997
$1.02
1주일 범위
Value
$0.9924
$1.15
52주 변동 폭
Value
$0.765
$4.1699

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
명칭
Adial Pharmaceuticals Inc
Name
전화
434-422-9800
Name
주소
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
직원
7
Name
트위터
@AdialPharma
Name
다음 수익 날짜
2024-12-12
Name
최신 SEC 제출 서류
Name
ADIL's Discussions on Twitter

ADIL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ADIL 1.01 6.47M 0 -6.07M -7.34M -7.54
VRTX 449.44 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.00 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.25 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.31 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.90 24.89B 3.30B -501.07M 1.03B 11.54

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2018-10-30 개시 Maxim Group Buy
2018-10-11 개시 Dawson James Buy

Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스

pulisher
Nov 16, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) Coverage Initiated at Rodman & Renshaw - Defense World

Nov 16, 2024
pulisher
Nov 16, 2024

RODMAN&RENSHAW Upgrades Adial Pharmaceuticals (NASDAQ:ADIL) to “Strong-Buy” - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Rodman & Renshaw sets stock target, buy rating on Adial Pharma, cites potential - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Adial Pharmaceutica - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

U.S. STOCKS Oklo, Adial Pharma, Sonos - XM

Nov 14, 2024
pulisher
Nov 14, 2024

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder - AOL

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals completes key study for FDA meeting - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Announces Positive Topline Results - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharma's AD04 Drug Hits Key Milestones in Alcohol Use Disorder Treatment Study | ADIL Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 14, 2024
pulisher
Nov 13, 2024

Adial Pharma Reports Mixed Q3: AUD Drug Study Advances Despite Widening Losses | ADIL Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 07, 2024

Adial Pharmaceuticals Appoints Vinay Shah as CFO - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

Adial Pharmaceuticals names new CFO amid strategic growth By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharmaceuticals names new CFO amid strategic growth - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Adial Pharma Taps Veteran CFO with $150M+ Fundraising Track Record | Key Executive Move | ADIL Stock News - StockTitan

Nov 05, 2024
pulisher
Oct 23, 2024

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference - The Manila Times

Oct 23, 2024
pulisher
Oct 17, 2024

EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate - AOL

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals Receives Notice of Allowance for U.S. - GlobeNewswire

Oct 17, 2024
pulisher
Oct 15, 2024

Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery - GlobeNewswire

Oct 15, 2024
pulisher
Sep 26, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 46.2% in September - Defense World

Sep 26, 2024
pulisher
Sep 19, 2024

Analyzing ADI’s price-to-book ratio for the last quarter - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals completes key study stage for AUD drug - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Analog Devices Inc. (ADI) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

MQS Management LLC Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Therapeutics Reports Profitable H1 2024 - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewswire

Sep 19, 2024
pulisher
Sep 18, 2024

Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) versus Galapagos (NASDAQ:GLPG) Head-To-Head Comparison - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 17% CAGR over 5 years, yet earnings have been shrinking - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Eagle-Tribune

Sep 18, 2024
pulisher
Sep 18, 2024

ADM Investor Services Singapore Becomes Abaxx Exchange's Third Clearing and Trading Member - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 17, 2024

Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion - Marketscreener.com

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics set to join S&P SmallCap 600 index By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Take off with Applied Dna Sciences Inc (APDN): Get ready for trading - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics Set to Join S&P SmallCap 600 Index - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 16, 2024

Adial Pharmaceuticals Inc (ADIL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):